Zeng Lab
Home
About
Professor Zeng Qi
Lab Members
Research
Publications
Contact
Gallery
More
PRL-3 activates mTORC1 in Cancer Progression
24 November 2015
Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia
8 August 2013
Tapping the treasure of intracellular oncotargets with immunotherapy
21 January 2014
Engineering the First Chimeric Antibody in Targeting Intracellular PRL-3 Oncoprotein for Cancer Therapy in Mice
27 February 2012
Targeting Intracellular Oncoproteins with Antibody Therapy or Vaccination
7 September 2011
PRL-3 phosphatase and cancer metastasis
04 November 2010
PRL-3 Down-regulates PTEN Expression and Signals through PI3K to Promote Epithelial-Mesenchymal Transition
04 April 2007
Generation of PRL-3- and PRL-1-Specific Monoclonal Antibodies as Potential Diagnostic Markers for Cancer Metastases
23 March 2005
PRL-3 and PRL-1 promote cell migration, invasion, and metastasis
1 June 2003
Mouse PRL-2 and PRL-3, Two Potentially Prenylated Protein Tyrosine Phosphatases Homologous to PRL-1
17 March 1998
A role of autophagy in PTP4A3-driven cancer progression
1 August 2014
Metastasis-associated PRL-3 induces EGFR activation and addiction in cancer cells
8 July 2013
Awaiting a new era of cancer immunotherapy
31 July 2012
The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemia
21 September 2012
PCBP1 Suppresses the Translation of Metastasis-Associated PRL-3 Phosphatase
13 July 2010
Monoclonal antibodies target intracellular PRL phosphatases to inhibit cancer metastases in mice
01 June 2008
PRL-3 Initiates Tumor Angiogenesis by Recruiting Endothelial Cells In vitro and In vivo
03 October 2006
Catalytic domain of PRL-3 plays an essential role in tumor metastasis: formation of PRL-3 tumors inside the blood vessels
23 July 2004
Prenylation-dependent Association of Protein-tyrosine Phosphatases PRL-1, -2, and -3 with the Plasma Membrane and the Early Endosome
July 2000
